MedTrace Logo

A Combined Psycho-pharmacological and Brain Imaging Study of Human Sexuality

NCT00569413 · Status: SUSPENDED · Type: OBSERVATIONAL · Enrollment: 40

Last updated 2010-06-10

No results posted yet for this study

Summary

The current study combines a molecular genetic perspective, self report and brain imaging to the study of human sexuality in control subjects and individuals from a sexual disorder clinic. The investigators hypothesize that the variability in components of the brain dopaminergic system expressed in the mesolimbic reward system can explain variability in human sexuality, especially in desire and pleasure associated with sex.

Conditions

Sponsors & Collaborators

  • Ben-Gurion University of the Negev

    collaborator OTHER

  • Hadassah Medical Organization

    lead OTHER

Principal Investigators

  • Aviv M Weinstein, Ph.D · Hadasah Medical Organization, Jerusalem Israel

Eligibility

Min Age
21 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2011-04-30
Primary Completion
2011-10-31
Completion
2011-10-31

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00569413 on ClinicalTrials.gov